The Persian Version of the Fear of Cancer Recurrence Inventory (FCRI): Translation and Evaluation of Its Psychometric Properties

Main Article Content

Fatemeh Sadat Bateni
Maryam Rahmatian
Ahmad Kaviani
Sebastian Simard
Mehdi Soleimani
Aliakbar Nejatisafa


Breast Cancer, linguistic validation, Fear of cancer recurrence inventory, Persian, Psychometric properties


Background: This study aimed to translate and validate the Fear of Cancer Recurrence Inventory (FCRI) questionnaire into Persian and to investigate its psychometric properties.

Methods: The FCRI was translated to Persian using a linguistic methodology according to WHO guidelines. A total of 450 breast cancer survivors who had the following inclusion criteria were included: time elapse of more than six months after the treatment prior to the study; absence ofobjective markers of recurrence, fluency in the Persian language, and signing the informed consent. Internal consistency was estimated with Cronbach's α coefficient and test-retest reliability with Interclass correlation.  Concurrent validity was estimated through Pearson’s correlation between the FCRI and Hospital Anxiety and Depression Scale (HADS). Principal component analysis (PCA) and confirmatory factor analysis (CFA) were employed to evaluate dimensionality.

Results: The Persian version was acceptable for patients. The content validity index (CVI) was 0.80.  The instrument had good test-retest reliability (ICC= 0.96) and internal consistency (Cronbach’s α=0.86).  PCA and CFA indicated that the factor structure of the Persian version was similar to the original questionnaire and had acceptable goodness of fit.  Correlations between the FCRI and HADS was remarkable (r= 0.252 – 0.639), indicating acceptable concurrent validity.

Conclusions: The Persian version of FCRI could be considered a good cross-cultural equivalent for the original English version. The questionnaire was a reliable and valid instrument in terms of internal consistency, test-retest reliability, and dimensionality.


1. Ganz PA. Cancer survivorship: a physicians’ perspective. In: Ganz PA, editor. Cancer survivorship, today and tomorrow. New York: Springer; 2007. 1-7.
2. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016 ;66(4):271-89.
3. Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16–24.
4. Hodges L, Humphris G. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psycho-Oncology. 2009;18(8):841–848.
5. Northouse LL. Mastectomy patients and the fear of cancer recurrence. Cancer Nurs. 1981;4(3):213–220.
6. Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27(36):6172–6179.
7. Hodgkinson K, Butow P, Hunt G, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: The CaSUN (Cancer Survivors’Unmet Needs measure). Psycho-Oncology. 2007; 16(9):796–804.
8. Hodgkinson K, Butow P, Hunt GE, et al. Breast cancer survivors’ supportive care needs 2–10 years after diagnosis. Support Care Cancer 2007; 15(5):515–523. Epub 2006 Nov 21.
9. Sanson-Fisher R, Girgis A, Boyes A, et al. The unmet supportive care needs of patients with cancer. Cancer. 2000; 88(1):226–238.
10. Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012; 21(6):571-87.
11. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; 7(3):300-22.
12. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009; 17(3):241-51.
13. Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, Lefebvre M, Savard J, Devins GM. Empirical validation of the English version of the Fear of Cancer Recurrence Inventory. Qual Life Res. 2016; 25(2):311-321.
14. Sartorius N, Janca A. Psychiatric assessment instruments developed by the World Health Organization. Social Psychiatry Psychiatr Epidemiol. 1996;31:55-69.
15. Zigmond AS, Snaith PR. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370.
16. Montazeri A, Vahdaninia M, Ebrahimi M, et al. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:14.
17. You J, Leung F, Lai KK, Fu K. Factor structure and psychometric properties of the Pathological Narcissism Inventory among Chinese university students. J Pers Assess. 2013; 95(3):309-18.
18. Nasser F, Takahashi T. The effect of using item parcels on Ad Hoc goodness-of-fit indexes in confirmatory factor analysis: An example using Sarason’s reactions to tests. Appl Measur Educ. 2003; 16: 75-97.
19. Yang C, Nay S, Hoyle RH. Three approaches to using lengthy ordinal scales in structural equation models: Parceling, latent scoring, and shortening scales. Appl Psychol Measur. 2010; 43: 122-142.
20. Meyers LS, Gamst G, Guarino AJ. Apllied multivariate research: design and interpretation 3rd Ed. Thousand Oaks, California: SAGE. 2017. 476.
21. Lynn MR. Determination and quantification of content validity. Nurs Res. 1986; 35: 82-5.